Activist Investors Circle Unilever, Peloton and Kohl’s
From www.nytimes.com
2022-01-24 12:30:05
Excerpt:
Nelson Peltz’s next target
Unilever has faced pressure on multiple fronts for weeks, including pushback from shareholders over its now-abandoned pursuit of GlaxoSmithKline’s consumer business. Now the consumer goods giant must deal with a potentially bigger headache: Trian Partners, the activist investment firm run by Nelson Peltz.
Trian has amassed a significant stake in Unilever, DealBook’s Michael de la Merced reports. It isn’t clear how big the firm’s holdings are, though Trian began buying shares before Unilever’s pursuit of the Glaxo business became public, according to a source.
Unilever has taken fire over strategic missteps. Investors and analysts scorned the $68 billion Glaxo bid, with Unilever’s shares falling sharply after the company said it still wanted to buy the business, despite being rejected three times. And another big Unilever shareholder accused the company of neglecting business fundamentals while overemphasizing its commitment to climate and…
